1. Home
  2. DFH vs AORT Comparison

DFH vs AORT Comparison

Compare DFH & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dream Finders Homes Inc.

DFH

Dream Finders Homes Inc.

N/A

Current Price

$15.57

Market Cap

1.7B

ML Signal

N/A

Logo Artivion Inc.

AORT

Artivion Inc.

N/A

Current Price

$36.25

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DFH
AORT
Founded
2008
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.1B
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
DFH
AORT
Price
$15.57
$36.25
Analyst Decision
Hold
Strong Buy
Analyst Count
2
5
Target Price
$26.00
$48.76
AVG Volume (30 Days)
474.9K
483.2K
Earning Date
05-28-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
165.62
EPS
2.14
0.21
Revenue
$4,322,848,000.00
$298,836,000.00
Revenue This Year
$1.48
$14.20
Revenue Next Year
$6.88
$11.17
P/E Ratio
$7.38
$170.81
Revenue Growth
N/A
18.01
52 Week Low
$14.88
$21.97
52 Week High
$31.10
$48.25

Technical Indicators

Market Signals
Indicator
DFH
AORT
Relative Strength Index (RSI) 23.69 37.19
Support Level N/A $34.35
Resistance Level $20.26 $44.29
Average True Range (ATR) 0.84 1.47
MACD -0.41 0.03
Stochastic Oscillator 9.67 36.54

Price Performance

Historical Comparison
DFH
AORT

About DFH Dream Finders Homes Inc.

Dream Finders Homes Inc designs, builds and sells homes in markets throughout the United States. The company's primary focus is on constructing and selling single-family homes across entry-level, first-time move-up, second-time move-up, and active adult markets. Its homebuilding operations are organized into four reportable segments: Southeast, Mid-Atlantic, Midwest, and Financial Services. It generates the maximum of its revenue from the Midwest segment.

About AORT Artivion Inc.

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

Share on Social Networks: